Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Conatus Pharmaceuticals
(CNAT)
Earnings
CNAT
May 1
Confirmed
Aug 2019
Nov 2019
Mar 2020
May 2020
-0.12
-0.09
-0.05
-0.02
Details
Expected EPS
N/A
Actual EPS
-0.1049
Surprise EPS
N/A
Surprise Percent
N/A
Description
Conatus Pharmaceuticals (CNAT) has reported earnings of -0.1049 per share for null.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login